From: Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?
 | Controls n = 20 | Patients n = 32 | p value |
---|---|---|---|
Aortic PWV (m/s) | 8.5 (1.4) | 9.8 (2.7) | <0.05 |
Brachial PWV (m/s) | 8.5 (1.2) | 9.0 (1.7) | 0.329 |
AIx (%) | 26.9 (15.9) | 32.3 (8.4) | 0.156 |
Peripheral SBP (mmHg) | 130 (16) | 138 (19) | 0.135 |
Peripheral DBP (mmHg) | 79 (8) | 82 (9) | 0.247 |
Peripheral PP (mmHg) | 51 (13) | 56 (15) | 0.196 |
Peripheral MAP (mmHg) | 96 (10) | 100 (11) | 0.177 |
Central SBP (mmHg) | 120 (16) | 125 (18) | 0.368 |
Central DBP (mmHg) | 80 (8) | 82 (11) | 0.621 |
Central PP (mmHg) | 40 (12) | 47 (18) | 0.133 |
Central MAP (mmHg) | 97 (10) | 104 (13) | 0.055 |
Heart rate (bpm) | 68 (11) | 77 (12) | <0.01 |
Fasting Glucose (mmol/L) | 5.2 (0.5) | 5.0 (0.6) | 0.236 |
Total Fasting Cholesterol (mmol/L) | 5.2 (1.2) | 5.6 (1.2) | 0.360 |
LDL (mmol/L) | 3.0 (1.2) | 3.3 (1.1) | 0.322 |
HDL (mmol/L) | 1.6 (0.7) | 1.7 (0.5) | 0.504 |
Cholesterol/HDL ratio | 3.8 (1.5) | 3.5 (1.0) | 0.373 |
Triglyceride (mmol/L) | 1.2 (0.6) | 1.1 (0.4) | 0.591 |
IL-6 †(pg/ml) | 1.3 (3.1) | 3.8 (2.1) | <0.001 |